Publication | Closed Access

Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: Protection by nitric oxide donor

BiochemistryLow-density LipoproteinMedicineDiabetesPhysiologyHyperlipidemiaVascular BiologyLipoprotein MetabolismNitric Oxide DonorPhospholipase A2PharmacologyAtherosclerosisDyslipidemiaOxidative Stress